Wellington Management Group LLP Reduces Position in HealthEquity, Inc. $HQY

Wellington Management Group LLP trimmed its position in HealthEquity, Inc. (NASDAQ:HQY) by 22.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 387,894 shares of the company’s stock after selling 109,626 shares during the quarter. Wellington Management Group LLP owned approximately 0.46% of HealthEquity worth $35,035,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of HQY. Acumen Wealth Advisors LLC acquired a new stake in HealthEquity in the fourth quarter valued at $27,000. Caitong International Asset Management Co. Ltd lifted its holdings in HealthEquity by 1,723.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after buying an additional 293 shares during the last quarter. Aster Capital Management DIFC Ltd purchased a new position in shares of HealthEquity in the 4th quarter valued at about $28,000. Leonteq Securities AG raised its position in shares of HealthEquity by 159.9% during the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after acquiring an additional 235 shares in the last quarter. Finally, Axiom Investment Management LLC acquired a new stake in shares of HealthEquity during the 1st quarter worth about $33,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Wall Street Analysts Forecast Growth

HQY has been the subject of several recent analyst reports. Barrington Research restated an “outperform” rating and set a $110.00 target price on shares of HealthEquity in a research note on Friday, May 22nd. Telsey Advisory Group set a $111.00 price objective on shares of HealthEquity in a report on Friday, August 28th. BTIG Research restated a “buy” rating and set a $115.00 price objective on shares of HealthEquity in a research report on Friday, August 28th. Raymond James Financial restated a “strong-buy” rating on shares of HealthEquity in a report on Thursday. Finally, Royal Bank Of Canada increased their target price on shares of HealthEquity from $100.00 to $108.00 and gave the company an “outperform” rating in a research report on Wednesday, June 3rd. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, HealthEquity currently has a consensus rating of “Moderate Buy” and an average price target of $111.87.

Insider Activity at HealthEquity

In other news, Director Adrian Dillon sold 7,632 shares of the business’s stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the transaction, the director owned 62,395 shares of the company’s stock, valued at approximately $6,527,140.95. The trade was a 10.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Fiore sold 2,470 shares of the company’s stock in a transaction that occurred on Thursday, July 2nd. The stock was sold at an average price of $95.00, for a total value of $234,650.00. Following the sale, the executive vice president owned 56,643 shares of the company’s stock, valued at $5,381,085. This trade represents a 4.18% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 12,456 shares of company stock worth $1,256,664 over the last quarter. Company insiders own 1.60% of the company’s stock.

HealthEquity Trading Down 2.7%

NASDAQ HQY opened at $96.07 on Friday. The firm’s fifty day moving average is $99.37 and its two-hundred day moving average is $88.61. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $107.62. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.99 and a current ratio of 2.99. The firm has a market cap of $7.95 billion, a PE ratio of 34.68, a P/E/G ratio of 1.56 and a beta of 0.22.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Thursday, August 27th. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.19 by $0.05. The business had revenue of $350.73 million during the quarter, compared to the consensus estimate of $349.22 million. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The company’s revenue for the quarter was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Analysts expect that HealthEquity, Inc. will post 3.93 earnings per share for the current year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.